Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance Treatment LITTLETON, Colo., July 01, 2025 (GLOBE ...

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance Jul. 01, 2025 8:30 AM ET Vivos Therapeutics, Inc. (VVOS) ...

Vivos Therapeutics' VidaSleep™ oral appliance receives CMS approval, expanding treatment options for obstructive sleep apnea and snoring.

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance TreatmentLITTLETON, Colo., July 01, 2025 ...

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance Treatment LITTLETON, Colo., July 01, 2025 (GLOBE ...

Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...

PORTLAND, OR, UNITED STATES, June 25, 2025 / EINPresswire.com / -- The global sleep apnea oral appliances market is on a sharp growth trajectory, projected to reach $2,337.7 million by 2031, up from ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

Daytime hypercapnia and obesity, obstructive airflow limitation, restrictive lung impairment, and severity of sleep apnea and the response to continuous positive airway pressure (CPAP) are examined.

ROCHESTER, Minn. (KTTC) – Dr. Katie Post, owner of Northwest Dental Group, is joining Midwest Access for Tooth Talk. She will answer your questions about oral cancer screenings, root canals, tooth ...